Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6195251 | 6886247 | F | 6195251-2 | 20090511 | 20090519 | EXP | FR-ELI_LILLY_AND_COMPANY-FR200901001232 | ELI LILLY AND COMPANY | 62 | YR | M | Y | 115 | KG | 20090519 | MD | FRANCE |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6195251 | 1011593957 | PS | BYETTA | 1 | SUBCUTANEOUS | 5 UG, 2/D | 021773 | ||||
| 6195251 | 1011593958 | SS | BYETTA | 1 | SUBCUTANEOUS | 10 UG, 2/D | 021773 | ||||
| 6195251 | 1011593959 | C | NOVONORM | 2 | ORAL | 12 MG, DAILY (1/D) | |||||
| 6195251 | 1011593960 | C | METFORMIN HCL | 1 | ORAL | 1000 MG, 3/D | |||||
| 6195251 | 1011593961 | C | ZANIDIP | 2 | |||||||
| 6195251 | 1011593962 | C | DIAMICRON | 2 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6195251 | 1011593957 | TYPE 2 DIABETES MELLITUS |
| 6195251 | 1011593959 | TYPE 2 DIABETES MELLITUS |
| 6195251 | 1011593960 | TYPE 2 DIABETES MELLITUS |
| 6195251 | 1011593962 | TYPE 2 DIABETES MELLITUS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6195251 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 6195251 | INFLUENZA LIKE ILLNESS |
| 6195251 | LIVER INJURY |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6195251 | 1011593957 | 20081101 | |||
| 6195251 | 1011593958 | 20081201 | |||
| 6195251 | 1011593959 | 20000101 | |||
| 6195251 | 1011593960 | 20000101 |